Country
Netherlands
The European Medicines Agency has concluded that the benefits of the AstraZeneca/Oxford University Covid-19 vaccine outweigh the risks despite a possible link to rare blood clots with low blood platelets.
Full text available to subscribers only. Click here for information on subscribing to MedNous.